Covid -19 Rehabilitation Beds

Award

Value

£2,520,000

Classifications

  • Health services

Tags

  • award
  • contract

Published

4 years ago

Description

This Award Notice is a extension to the Contract that was awarded under notice 2020/S 100-243393.
The Covid-19 outbreak has given rise to an urgent need to commission services to support discharges from acute hospitals, including the commissioning of therapy services to support patients discharged to their own homes or to discharge to assess beds.
Under the Public Contracts Regulations 2015, the Contracting Authority considers COVID-19 to be a state of urgency that has been brought about by circumstances which a diligent contracting authority could not have foreseen.
Although it seems that the worst phase of the Covid-19 pandemic has passed (1st and 2nd wave), its direct and indirect impacts such as reduced acute bed capacity, workforce issues, fragile social care market continue to put the health system under an unprecedent high level of pressure which coupled with uncertainty regarding funding arrangements for the next 6-12 months is making an already challenging situation even more challenging and complex. 
Accordingly, the Hampshire, Southampton and Isle of Wight CCG (HSIOW CCG) decided to further extend its contract with Hobbs Rehabilitation until 31st March 2022 using the 'competitive procedure without prior publication for reasons of extreme urgency', brought about by the COVID-19 outbreak. 
Under the contract extension, Hobbs Rehabilitation will provide occupational therapy and physiotherapy to patients discharged to discharge to assess beds across the North and Mid Hampshire area from 9am-5pm 5 days a week however, it is expected the provider shall adapt those hours when required in line with care home handovers. The Provider shall provide comprehensive rehabilitation for this patient group to facilitate accelerated discharge into home. 
The total maximum contract value up until 31st March 2022 will be £2.52M however, this may fluctuate due to unknown demand and uncertainty in managing surge and associated funding.
This PCR Regulation 32 Contract Award notice is being published to notify the award of the contract until 31st March 2022. This time is considered necessary and proportional to alleviate the direct and indirect risks posed by the Covid-19 outbreak and will give the above named Contracting Authority sufficient time to comply with undertaking a compliant competitive procurement process under the Public Contracts Regulations 2015.

Similar Contracts

Open

Provision of Hypertension and Lipids Management Services

NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete